The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
Open accessAbstract
SQ109, a 1,2-diamine related to ethambutol, is currently in clinical trials for the treatment of tuberculosis, but its mode of action remains unclear. Here, we demonstrate that SQ109 disrupts cell wall assembly, as evidenced by macromolecular incorporation assays and ultrastructural analyses. SQ109 interferes with the assembly of mycolic acids into the cell wall core of Mycobacterium tuberculosis , as bacilli exposed to SQ109 show immediate inhibition of trehalose dimycolate (TDM) production and fail to attach mycolates to the cell wall arabinogalactan. These effects were not due to inhibition of mycolate synthesis, since total mycolate levels were unaffected, but instead resulted in the accumulation of trehalose monomycolate (TMM), the precursor of TDM and cell wall mycolates. In vitro assays using purified enzymes showed that this was not due to inhibition of the secreted Ag85 mycolyltransferases. We were unable to achieve spontaneous generation of SQ109-resistant mutants; however, analogs of this compound that resulted in similar shutdown of TDM synthesis with concomitant TMM accumulation were used to spontaneously generate resistant mutants that were also cross-resistant to SQ109. Whole-genome sequencing of these mutants showed that these all had mutations in the essential mmpL3 gene, which encodes a transmembrane transporter. Our results suggest that MmpL3 is the target of SQ109 and that MmpL3 is a transporter of mycobacterial TMM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Genes required for mycobacterial growth defined by high density mutagenesis
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03425.x · Cited by 2,544
Brennan, P. J., & Nikaido, H. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000333 · Cited by 1,985
Global tuberculosis control 2010
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,262
Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis
Brennan, P. J. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00089-6 · Cited by 884
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Makarov, V., Manina, G., Mikusova, K., Möllmann, U., Ryabova, O., Saint-Joanis, B., Dhar, N., Pasca, M. R., Buroni, S., Lucarelli, A. P., et al. (2009) · Science · doi:10.1126/science.1171583 · Cited by 740
Role of the Major Antigen of Mycobacterium tuberculosis in Cell Wall Biogenesis
Belisle, J. T., Vissa, V. D., Sievert, T., Takayama, K., Brennan, P. J., & Besra, G. S. (1997) · Science · doi:10.1126/science.276.5317.1420 · Cited by 734
The Envelope Layers of Mycobacteria with Reference to their Pathogenicity
Daffé, M., & Draper, P. (1997) · Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60016-8 · Cited by 730
Treatment for tuberculosis, guidelines for national programmes
Gyselen, E. A. (1994) · Health Policy · doi:10.1016/0168-8510(94)90025-6 · Cited by 708
Pathway to Synthesis and Processing of Mycolic Acids in Mycobacterium tuberculosis
Takayama, K., Wang, C., & Besra, G. S. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.81-101.2005 · Cited by 660
The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism
Boshoff, H. I. M., Myers, T. G., Copp, B. R., McNeil, M. R., Wilson, M. A., & Barry, C. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406796200 · Cited by 606
Self-citationHoffmann, C., Leis, A., Niederweis, M., Plitzko, J. M., & Engelhardt, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709530105 · Cited by 596
Mycolic acids: structure, biosynthesis and physiological functions
Barry, C. E., Lee, R. E., Mdluli, K., Sampson, A. E., Schroeder, B. G., Slayden, R. A., & Yuan, Y. (1998) · Progress in Lipid Research · doi:10.1016/s0163-7827(98)00008-3 · Cited by 565
Self-citationMechanisms of RND multidrug efflux pumps
Nikaido, H., & Takatsuka, Y. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.10.004 · Cited by 555
Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
Hugonnet, J.-E., Tremblay, L. W., Boshoff, H. I., Barry, C. E., & Blanchard, J. S. (2009) · Science · doi:10.1126/science.1167498 · Cited by 494
Self-citationDirect Visualization of the Outer Membrane of Mycobacteria and Corynebacteria in Their Native State
Zuber, B., Chami, M., Houssin, C., Dubochet, J., Griffiths, G., & Daffé, M. (2008) · Journal of Bacteriology · doi:10.1128/jb.01919-07 · Cited by 458 · cited 1×
“posed to explain the unexpectedly thin and symmetrical nature of the core (27, 74).”
BackgroundAnalysis of the Phthiocerol Dimycocerosate Locus ofMycobacterium tuberculosis
Camacho, L. R., Constant, P., Raynaud, C., Lanéelle, M.-A., Triccas, J. A., Gicquel, B., Daffé, M., & Guilhot, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100662200 · Cited by 382
Protopopova, M., Hanrahan, C., Nikonenko, B., Samala, R., Chen, P., Gearhart, J., Einck, L., & Nacy, C. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki319 · Cited by 371
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
Takayama, K., & Kilburn, J. O. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1493 · Cited by 369
Contribution of the Mycobacterium tuberculosis MmpL Protein Family to Virulence and Drug Resistance
Domenech, P., Reed, M. B., & Barry, C. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3492-3501.2005 · Cited by 361
Self-citationLamichhane, G., Zignol, M., Blades, N. J., Geiman, D. E., Dougherty, A., Grosset, J., Broman, K. W., & Bishai, W. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1231432100 · Cited by 357
The Mechanism of Isoniazid Killing: Clarity Through the Scope of Genetics
Vilchèze, C., & Jacobs, Jr. (2007) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.111606.122346 · Cited by 335
Sani, M., Houben, E. N. G., Geurtsen, J., Pierson, J., de Punder, K., van Zon, M., Wever, B., Piersma, S. R., Jiménez, C. R., Daffé, M., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000794 · Cited by 311
Elkins, C. A., & Nikaido, H. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.23.6490-6499.2002 · Cited by 303
Biogenesis of the mycobacterial cell wall and the site of action of ethambutol
Mikusová, K., Slayden, R. A., Besra, G. S., & Brennan, P. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2484 · Cited by 301
Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis
Crick, D. C., Mahapatra, S., & Brennan, P. J. (2001) · Glycobiology · doi:10.1093/glycob/11.9.107r · Cited by 293
Takayama, K., Wang, L., & David, H. L. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.1.29 · Cited by 292
Mycolic Acid Structure Determines the Fluidity of the Mycobacterial Cell Wall
Liu, J., Barry, C. E., Besra, G. S., & Nikaido, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29545 · Cited by 288
Self-citationJackson, M., Raynaud, C., Lanéelle, M., Guilhot, C., Laurent‐Winter, C., Ensergueix, D., Gicquel, B., & Daffé, M. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01310.x · Cited by 267
The Methyl-Branched Fortifications of Mycobacterium tuberculosis
Minnikin, D. E., Kremer, L., Dover, L. G., & Besra, G. S. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00142-4 · Cited by 262
Prideaux, B., Dartois, V., Staab, D., Weiner, D. M., Goh, A., Via, L. E., Barry, C. E., & Stoeckli, M. (2011) · Analytical Chemistry · doi:10.1021/ac1029049 · Cited by 260
Self-citationMmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence
Converse, S. E., Mougous, J. D., Leavell, M. D., Leary, J. A., Bertozzi, C. R., & Cox, J. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1030024100 · Cited by 250
Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis
Backus, K. M., Boshoff, H. I., Barry, C. S., Boutureira, O., Patel, M. K., D'Hooge, F., Lee, S. S., Via, L. E., Tahlan, K., Barry, C. E., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.539 · Cited by 237
Self-citationPharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug
Jia, L., Tomaszewski, J. E., Hanrahan, C., Coward, L., Noker, P., Gorman, G., Nikonenko, B., & Protopopova, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705984 · Cited by 231
Chapter 2 Biogenesis of the Cell Wall and Other Glycoconjugates of Mycobacterium tuberculosis
Kaur, D., Guerin, M. E., Škovierová, H., Brennan, P. J., & Jackson, M. (2009) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(09)69002-x · Cited by 226
Lee, R. E., Protopopova, M., Crooks, E., Slayden, R. A., Terrot, M., & Barry, C. E. (2003) · Journal of Combinatorial Chemistry · doi:10.1021/cc020071p · Cited by 207
Self-citationColangeli, R., Helb, D., Sridharan, S., Sun, J., Varma‐Basil, M., Hazbón, M. H., Harbacheuski, R., Megjugorac, N. J., Jacobs, W. R., Holzenburg, A., et al. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04510.x · Cited by 188
Self-citationWolucka, B. A. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06395.x · Cited by 182
Physical organization of lipids in the cell wall of Mycobacterium chelonae
Nikaido, H., Kim, S., & Rosenberg, E. Y. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01647.x · Cited by 178
Alland, D., Steyn, A. J., Weisbrod, T., Aldrich, K., & Jacobs, W. R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.7.1802-1811.2000 · Cited by 165
Self-citationThe Role of MmpL8 in Sulfatide Biogenesis and Virulence of Mycobacterium tuberculosis
Domenech, P., Reed, M. B., Dowd, C. S., Manca, C., Kaplan, G., & Barry, C. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400324200 · Cited by 163
Self-citationMutations in gidB Confer Low-Level Streptomycin Resistance in Mycobacterium tuberculosis
Wong, S. Y., Lee, J. S., Kwak, H.-K., Via, L. E., Boshoff, H. I., & Barry, C. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01814-10 · Cited by 160
Self-citationFluidity of the lipid domain of cell wall from Mycobacterium chelonae.
Liu, J., Rosenberg, E. Y., & Nikaido, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11254 · Cited by 150
Nikonenko, B. V., Protopopova, M. N., Samala, R., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01326-06 · Cited by 143
The outer parts of the mycobacterial envelope as permeability barriers
Draper, P. (1998) · Frontiers in bioscience · doi:10.2741/a360 · Cited by 132
Jain, M., & Cox, J. S. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010002 · Cited by 130
Targeting the Formation of the Cell Wall Core of M. tuberculosis
Barry, C. E., Crick, D. C., & McNeil, M. (2007) · Infectious Disorders - Drug Targets · doi:10.2174/187152607781001808 · Cited by 120
Self-citationThe M. tuberculosis antigen 85 complex and mycolyltransferase activity
Kremer, L., Maughan, W. N., Wilson, R. A., Dover, L. G., & Besra, G. S. (2002) · Letters in Applied Microbiology · doi:10.1046/j.1472-765x.2002.01091.x · Cited by 110
Self-citationThe Targets of Currently Used Antibacterial Agents: Lessons for Drug Discovery
Lange, R., Locher, H. H., Wyss, P. C., et al. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207782110408 · Cited by 107
Puech‐Pagès, V., Bayan, N., Salim, K., Leblon, G., & Daffé, M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01738.x · Cited by 106
Interspecies pharmacokinetics and in vitro metabolism of SQ109
Jia, L., Noker, P. E., Coward, L. C., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706650 · Cited by 102
Bergval, I., Schuitema, A. R. J., Klatser, P. R., & Anthony, R. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp237 · Cited by 97
Identification of the apparent carrier in mycolic acid synthesis.
Besra, G. S., Sievert, T. R., Lee, R. E., Jr., Slayden, R. A., Brennan, P. J., & Takayama, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12735 · Cited by 90
Tropis, M., Méniche, X., Wolf, A., Gebhardt, H., Strelkov, S., Chami, M., Schomburg, D., Krämer, R., Morbach, S., & Daffé, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502104200 · Cited by 81
Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium
Mdluli, K. E., Swanson, J., Fischer, E. R., Lee, R. E., Jr., & Barry, C. E. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00774.x · Cited by 74
Self-citationThe chemical biology of new drugs in the development for tuberculosis
Barry, C. E., & Blanchard, J. S. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.04.008 · Cited by 68
Self-citationWang, L., Slayden, R. A., Barry, C. E., & Liu, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7224 · Cited by 66
Self-citationBhatt, A., Brown, A. K., Singh, A., Minnikin, D. E., & Besra, G. S. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.07.007 · Cited by 64
Analysis of the Lipids of Mycobacterium tuberculosis
Slayden, R. A., & Barry, C. E. (2003) · Humana Press eBooks · doi:10.1385/1-59259-147-7:229 · Cited by 63
Self-citationd’Auria, C. D. S., Kacem, R., Puech‐Pagès, V., Tropis, M., Leblon, G., Houssin, C., & Daffé, M. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00396-3 · Cited by 53
Jia, L., Coward, L. C., Gorman, G. S., Noker, P. E., & Tomaszewski, J. E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087817 · Cited by 48
Hancock, I. C., Carman, S., Besra, G. S., Brennan, P. J., & Waite, E. (2002) · Microbiology · doi:10.1099/00221287-148-10-3059 · Cited by 40
Heifets, L. B., Lindholm-Levy, P. J., & Flory, M. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.2.268 · Cited by 32
Mycolic Acid/Cyclopropane Fatty Acid/Fatty Acid Biosynthesis and Health Relations
Kastrinsky, D. B., McBride, N. S., Backus, K. M., LeBlanc, J. J., & Barry, C. E. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00029-0 · Cited by 11
Self-citation
Cited by
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 893
DeJesus, M. A., Gerrick, E. R., Xu, W., Park, S. W., Long, J. E., Boutte, C. C., Rubin, E. J., Schnappinger, D., Ehrt, S., Fortune, S. M., et al. (2017) · mBio · doi:10.1128/mbio.02133-16 · Cited by 668
Mycolic Acids: Structures, Biosynthesis, and Beyond
Marrakchi, H., Lanéelle, M.-A., & Daffé, M. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.11.011 · Cited by 623
Drug Resistance Mechanisms in Mycobacterium tuberculosis
Palomino, J., & Martin, A. (2014) · Antibiotics · doi:10.3390/antibiotics3030317 · Cited by 442
Antibiotics in the clinical pipeline in 2013
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.86 · Cited by 433
Metadata
- Authors
- Tahlan, K., Wilson, R., Kastrinsky, D. B., Arora, K., Nair, V., Fischer, E., Barnes, S. W., Walker, J. R., Alland, D., Barry, C. E., & Boshoff, H. I.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2012-04
- Volume
- 56
- Issue
- 4
- Pages
- 1797-1809
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2155375392
- Cited by
- 504
- References
- 65
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.